Travis Jon Short, DO | |
1200 E Michigan Ave Ste 245, Lansing, MI 48912-1897 | |
(517) 364-5252 | |
Not Available |
Full Name | Travis Jon Short |
---|---|
Gender | Male |
Speciality | Family Practice |
Experience | 7 Years |
Location | 1200 E Michigan Ave Ste 245, Lansing, Michigan |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1073033197 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207Q00000X | Family Medicine | 5101023443 (Michigan) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
Edward W Sparrow Hospital | Lansing, MI | Hospital |
Sparrow Clinton Hospital | Saint johns, MI | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Edward W Sparrow Hospital Association | 6709799166 | 522 |
News Archive
For people with weight problems, news headlines in recent years may have brought relief, as researchers studying the microscopic creatures inside our bodies reported possible links between obesity and an out-of-whack balance of microbes.
The Berlin Institute for Medical Systems Biology (BIMSB) of the Max Delbr-ck Center for Molecular Medicine (MDC) in Berlin, Germany, will be the first academic research institution in Continental Europe to acquire a novel DNA sequencer enabling the sequencing of single DNA molecules in real time.
Looking to identify new strategies to prevent breast cancer recurrence, a research team led by Subhamoy Dasgupta, PhD, Assistant Professor of Oncology in the Department of Cell Stress Biology at Roswell Park Comprehensive Cancer Center, has identified two key proteins involved in glucose metabolism that could be targeted to prevent breast cancer metastasis and recurrence. The team's findings were published today in the journal Nature.
Mylan Inc. today announced that its subsidiary Mylan Pharmaceuticals Inc. received final approval from the U.S. Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for Polyethylene Glycol 3350, Sodium Chloride, Sodium Bicarbonate and Potassium Chloride for Oral Solution (with Flavor Packs), the generic version of Braintree Laboratories' NuLytely® laxative.
Bristol scientists have discovered a novel pathology that occurs in several human neurodegenerative diseases, including Huntington's disease.
› Verified 1 days ago
Entity Name | Edward W Sparrow Hospital Association |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1831139088 PECOS PAC ID: 6709799166 Enrollment ID: O20040102000790 |
News Archive
For people with weight problems, news headlines in recent years may have brought relief, as researchers studying the microscopic creatures inside our bodies reported possible links between obesity and an out-of-whack balance of microbes.
The Berlin Institute for Medical Systems Biology (BIMSB) of the Max Delbr-ck Center for Molecular Medicine (MDC) in Berlin, Germany, will be the first academic research institution in Continental Europe to acquire a novel DNA sequencer enabling the sequencing of single DNA molecules in real time.
Looking to identify new strategies to prevent breast cancer recurrence, a research team led by Subhamoy Dasgupta, PhD, Assistant Professor of Oncology in the Department of Cell Stress Biology at Roswell Park Comprehensive Cancer Center, has identified two key proteins involved in glucose metabolism that could be targeted to prevent breast cancer metastasis and recurrence. The team's findings were published today in the journal Nature.
Mylan Inc. today announced that its subsidiary Mylan Pharmaceuticals Inc. received final approval from the U.S. Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for Polyethylene Glycol 3350, Sodium Chloride, Sodium Bicarbonate and Potassium Chloride for Oral Solution (with Flavor Packs), the generic version of Braintree Laboratories' NuLytely® laxative.
Bristol scientists have discovered a novel pathology that occurs in several human neurodegenerative diseases, including Huntington's disease.
› Verified 1 days ago
Mailing Address | Practice Location Address |
---|---|
Travis Jon Short, DO 1200 E Michigan Ave Ste 245, Lansing, MI 48912-1897 Ph: (517) 364-5252 | Travis Jon Short, DO 1200 E Michigan Ave Ste 245, Lansing, MI 48912-1897 Ph: (517) 364-5252 |
News Archive
For people with weight problems, news headlines in recent years may have brought relief, as researchers studying the microscopic creatures inside our bodies reported possible links between obesity and an out-of-whack balance of microbes.
The Berlin Institute for Medical Systems Biology (BIMSB) of the Max Delbr-ck Center for Molecular Medicine (MDC) in Berlin, Germany, will be the first academic research institution in Continental Europe to acquire a novel DNA sequencer enabling the sequencing of single DNA molecules in real time.
Looking to identify new strategies to prevent breast cancer recurrence, a research team led by Subhamoy Dasgupta, PhD, Assistant Professor of Oncology in the Department of Cell Stress Biology at Roswell Park Comprehensive Cancer Center, has identified two key proteins involved in glucose metabolism that could be targeted to prevent breast cancer metastasis and recurrence. The team's findings were published today in the journal Nature.
Mylan Inc. today announced that its subsidiary Mylan Pharmaceuticals Inc. received final approval from the U.S. Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for Polyethylene Glycol 3350, Sodium Chloride, Sodium Bicarbonate and Potassium Chloride for Oral Solution (with Flavor Packs), the generic version of Braintree Laboratories' NuLytely® laxative.
Bristol scientists have discovered a novel pathology that occurs in several human neurodegenerative diseases, including Huntington's disease.
› Verified 1 days ago
Daniel Francis Bouchard, D.O. Family Medicine Medicare: Medicare Enrolled Practice Location: 1215 E Michigan Ave, Osteopathic Internship Sparrow Hospital, Lansing, MI 48912 Phone: 231-955-3360 | |
Dr. Deja Danielle Rice, MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: Sparrow Health Systems 1215 E Michigan Avenue, Lansing, MI 48912 Phone: 517-364-5710 | |
Shimia Isaac, D.O. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1200 E Michigan Ave, Suite 245, Lansing, MI 48912 Phone: 517-364-5772 | |
Katrina Anne Weirauch Engle, D.O. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1200 E Michigan Ave, Suite 245-c, Lansing, MI 48912 Phone: 517-364-5772 Fax: 517-364-5764 | |
David Jonathan Pohl, D.O. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1540 Lake Lansing Rd Ste 202, Lansing, MI 48912 Phone: 517-913-3820 Fax: 517-913-3821 | |
Dr. Harshini A Jayasuriya, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 120 N Washington Sq Ste 300, Lansing, MI 48933 Phone: 517-258-0344 Fax: 517-879-0374 | |
Juan Jose Montoya Novoa, MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: Sparrow Health Systems 1215 E Michigan Ave, Lansing, MI 48912 Phone: 517-364-5710 |